Literature DB >> 7620231

The effects of ACE inhibitors on cognitive function.

A A O'Brien1, C J Bulpitt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7620231     DOI： 10.2165/00002512-199506030-00001

Source DB:  PubMed          Journal:  Drugs Aging        ISSN： 1170-229X            Impact factor:   3.923


× No keyword cloud information.
  53 in total

1.  The effects of anti-hypertensive medication on learning and memory.

Authors:  J Powell; A Pickering; M Wyke; T Goggin
Journal:  Br J Clin Pharmacol       Date:  1993-02       Impact factor: 4.335

2.  Hypertensive black men and women. Quality of life and effects of antihypertensive medications. Black Hypertension Quality of Life Multicenter Trial Group.

Authors:  S H Croog; B W Kong; S Levine; M R Weir; R M Baume; E Saunders
Journal:  Arch Intern Med       Date:  1990-08

3.  Differential effects of atenolol and enalapril on memory during treatment for essential hypertension.

Authors:  I Lichter; P J Richardson; M A Wyke
Journal:  Br J Clin Pharmacol       Date:  1986-06       Impact factor: 4.335

4.  The effect of fosinopril sodium on cerebral blood flow in moderate essential hypertension.

Authors:  G Waldemar; H Ibsen; S Strandgaard; A R Andersen; S Rasmussen; O B Paulson
Journal:  Am J Hypertens       Date:  1990-06       Impact factor: 2.689

5.  Differentiation of angiotensin-converting enzyme (ACE) inhibitors by their selective inhibition of ACE in physiologically important target organs.

Authors:  D W Cushman; F L Wang; W C Fung; C M Harvey; J M DeForrest
Journal:  Am J Hypertens       Date:  1989-04       Impact factor: 2.689

6.  The effects of verapamil and propranolol on quality of life in hypertension.

Authors:  A E Fletcher; P C Chester; C M Hawkins; A N Latham; L A Pike; C J Bulpitt
Journal:  J Hum Hypertens       Date:  1989-04       Impact factor: 3.012

7.  Central effects of the angiotensin-converting enzyme inhibitor, captopril. I. Performance and subjective assessments of mood.

Authors:  D Currie; R V Lewis; D G McDevitt; A N Nicholson; N A Wright
Journal:  Br J Clin Pharmacol       Date:  1990-10       Impact factor: 4.335

Review 8.  Cognitive function and angiotensin-converting enzyme inhibitors in comparison with other antihypertensive drugs.

Authors:  C J Bulpitt; A E Fletcher
Journal:  J Cardiovasc Pharmacol       Date:  1992       Impact factor: 3.105

9.  Impairment of memory function by antihypertensive medication.

Authors:  S Solomon; E Hotchkiss; S M Saravay; C Bayer; P Ramsey; R S Blum
Journal:  Arch Gen Psychiatry       Date:  1983-10

10.  The effects of captopril vs atenolol on memory, information processing and mood: a double-blind crossover study.

Authors:  I J Deary; S Capewell; C Hajducka; A L Muir
Journal:  Br J Clin Pharmacol       Date:  1991-09       Impact factor: 4.335
View more
  4 in total

1.  A substudy protocol of the hypertension in the Very Elderly Trial assessing cognitive decline and dementia incidence (HYVET-COG) : An ongoing randomised, double-blind, placebo-controlled trial.

Authors:  Ruth Peters; Nigel Beckett; Maria Nunes; Astrid Fletcher; Françoise Forette; Christopher Bulpitt
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

2.  Do nonsteroidal anti-inflammatory drugs have a protective effect against dementia?

Authors:  F L Van Muiswinkel; P Eikelenboom
Journal:  Drugs Aging       Date:  1996-07       Impact factor: 3.923

Review 3.  Cognition enhancers in age-related cognitive decline.

Authors:  W J Riedel; J Jolles
Journal:  Drugs Aging       Date:  1996-04       Impact factor: 3.923

4.  Quality of life in chronic heart failure: cilazapril and captopril versus placebo. Cilazapril-Captopril Multicentre Group.

Authors:  C J Bulpitt; A E Fletcher; L Dössegger; A Neiss; T Nielsen; S Viergutz
Journal:  Heart       Date:  1998-06       Impact factor: 5.994
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.